EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Left atrial appendage closure in end‐stage renal disease and hemodialysis: Data from a German multicenter registry

Thomas Fink iD, Christina Paitazoglou iD, Martin W Bergmann, Makoto Sano iD, Ahmad Keelani, Vanessa Sciacca, Mohammed Saad, Charlotte Eitel, Christian-Hendrik Heeger, Carsten Skurk, Ulf Landmesser iD, Holger Thiele und 8 weitere

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30559 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Thomas Fink und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology and Intensive Care Medicine-Division of Electrophysiology, University Heart Center Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Stroke, Atrial Appendage, Atrial Fibrillation, Kidney Failure, Chronic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Left atrial appendage closure (LAAC) has emerged as an alternative to oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation (AF). OAC treatment has been proven feasible in mild‐to‐moderate chronic kidney disease (CKD). In contrast, the optimal antithrombotic management of AF patients with end‐stage renal disease (ESRD) is unknown and LAAC has not been proven in these patients in prospective randomized clinical trials.

Objectives

The objective of this study is to evaluate safety and efficacy of LAAC in patients with ESRD.

Methods

Patients undergoing LAAC were collected in a German multicenter real‐world observational registry. A composite endpoint consisting of the occurrence of ischemic stroke/transient ischemic attack, systemic embolism, and/or major clinical bleeding was assessed. Patients with ESRD were compared with propensity score‐matched patients without severe CKD. ESRD was defined as a glomerular filtration rate < 15 ml/min/1.73 m 2 or chronic hemodialysis treatment.

Results

A total of 604 patients were analyzed, including 57 with ESRD and 57 propensity‐matched patients. Overall, 596 endocardial and 8 epicardial LAAC procedures were performed. Frequency of major complications was 7.0% (42/604 patients) in the overall cohort, 8.8% (5/57 patients) in patients with ESRD, and 10.5% (6/57 patients) in matched controls ( p = 0.75). The estimated event‐free survival of the combined endpoint after 500 days was 90.7 ± 4.5% in patients with ESRD and 90.2 ± 5.5% in matched controls ( p = 0.33).

Conclusions

LAAC had comparable procedural safety and clinical efficacy in patients with ESRD and patients without severe CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeAtrial AppendageAtrial FibrillationKidney Failure, ChronicRenal Insufficiency, ChronicHumansTreatment OutcomeProspective StudiesRenal DialysisRegistriesAnticoagulants

Stichwörter der Autor:innen

chronic kidney diseasehemodialysisleft atrial appendage closurerenal failurestroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Cardiology, Angiology and Intensive Care Medicine-Division of Electrophysiology, University Heart Center Lübeck, Lübeck, Germany.
  • Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
  • Interventional Cardiology, Cardiologicum Hamburg, Hamburg, Germany.
  • Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lübeck, Lübeck, Germany.
  • Department of Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site, Hamburg/Kiel/Lübeck, Germany.

ORCID-Profile: Thomas Fink, Christina Paitazoglou, Makoto Sano, Ulf Landmesser, Georg Fuernau

Zitieren

APA

Fink, T., Paitazoglou, C., Bergmann, M. W., Sano, M., Keelani, A., Sciacca, V., Saad, M., Eitel, C., Heeger, C. H., Skurk, C., Landmesser, U., Thiele, H., Stiermaier, T., Fuernau, G., Reil, J. C., Frey, N., Kuck, K. H., Tilz, R. R., Sandri, M., & Eitel, I. (2023). Left atrial appendage closure in end‐stage renal disease and hemodialysis: Data from a German multicenter registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30559

Vancouver

Fink T, Paitazoglou C, Bergmann MW, Sano M, Keelani A, Sciacca V, et al. Left atrial appendage closure in end‐stage renal disease and hemodialysis: Data from a German multicenter registry. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30559

BibTeX
@article{Fink2023,
  author = {Fink, Thomas and Paitazoglou, Christina and Bergmann, Martin W and Sano, Makoto and Keelani, Ahmad and Sciacca, Vanessa and Saad, Mohammed and Eitel, Charlotte and Heeger, Christian-Hendrik and Skurk, Carsten and Landmesser, Ulf and Thiele, Holger and Stiermaier, Thomas and Fuernau, Georg and Reil, Jan-Christian and Frey, Norbert and Kuck, Karl-Heinz and Tilz, Roland R and Sandri, Marcus and Eitel, Ingo},
  title = {Left atrial appendage closure in end‐stage renal disease and hemodialysis: Data from a German multicenter registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30559}
}
Kostenlos starten →